A Comparison of Outcome of Pulpotomy on Immature Permanent Molars Between Different Calcium Silicate-based Materials : a 12 Months Clinical Study
1 other identifier
interventional
48
1 country
1
Brief Summary
Preservation of pulp vitality through vital pulp therapy (VPT) has emerged in contemporary endodontics, particularly for immature permanent teeth. In cases of irreversible pulpitis, recent literature suggests that clinical symptoms do not always correlate with histopathological findings, supporting the use of conservative approaches such as full pulpotomy. This is especially relevant in young patients where continued root development and apical closure are critical for long-term tooth integrity and functionality. Immature teeth, due to their high cellularity and vascularity, exhibit a greater regenerative capacity, making them indicated for biologically based treatments. Among the materials used for VPT, calcium silicate-based cements (CSCs) have demonstrated good biological and physicochemical properties, including high biocompatibility, antimicrobial effects, alkaline pH, and sustained release of calcium ions that stimulate biomineralization. Mineral Trioxide Aggregate (MTA) has long been considered the gold standard; however, it is associated with several clinical limitations such as extended setting time, complex handling, and potential tooth discoloration. To address these drawbacks, newer generation premixed bioceramics have been introduced. These include NeoPUTTY®, Total Fill® BC UNIVERSAL RRM™, and Bio-C® Repair, each exhibiting unique compositional and functional properties designed to enhance clinical performance and ease of use. Despite promising individual results, no clinical study has yet compared these three materials within the context of pulpotomy in immature permanent molars with irreversible pulpitis. This randomized clinical trial aims to fill this gap by evaluating their clinical and radiographic outcomes over a 12-month period, to better guide material selection in vital pulp therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Oct 2025
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 29, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 27, 2027
January 20, 2026
January 1, 2026
1.4 years
November 29, 2025
January 9, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
-Root formation and apical closure.
Continued root formation and apical closure will be assessed using standardized periapical radiographs of the treated immature permanent molars and classified according to Cvek's stages of root development. Radiographic evaluation will be performed by a calibrated examiner. Progression in root development will be determined by changes in root length and apical foramen morphology compared with baseline. Cvek's classification includes five radiographic stages of root development: Stage I (A): \< 1/2 root length Stage II (B): 1/2 root length Stage III (C): 2/3 root length Stage IV (D): Nearly complete root length with wide open apical foramen Stage V (E): Complete root development with closed apical foramen
12 months
-Postoperative pain. -Percussion and/or palpation pain.
Pain response will be recorded as a binary outcome (Yes/No) based on the patient's subjective report during standardized clinical examination. The assessment will be performed by a calibrated examiner using gentle vertical percussion and periapical palpation according to routine endodontic diagnostic procedures. Measurement Tool Clinical percussion test Clinical palpation test Patient-reported pain response during examination (verbal report) Postoperative pain assessed using a Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (worst pain imaginable), recorded by the patient.
12 months
Other Outcomes (1)
-Presence of periapical lesion.
12 months
Study Arms (3)
Neo PUTTY (Nusmile Inc, Houston, TX; USA)
EXPERIMENTALpremixed bioactive bioceramic composed of an inorganic powder containing tricalcium and dicalcium silicate in a water-free organic liquid.
Total Fill® BC UNIVERSAL RRM™ (FKG Dentaire, Switzerland)
ACTIVE COMPARATORpremixed bioceramic material composed of calcium aluminosilicate paste designed for permanent root canal repair and surgical applications.
Bio-C® Repair (BCR; Angelus, Londrina, Brazil)
ACTIVE COMPARATORnew ready-to-use bioceramic repair material. Bio-C has indications similar to MTA and is composed of calcium silicates \[tricalcium silicate, dicalcium silicate\], tricalcium aluminate, calcium oxide (for the release of calcium ions), and zirconium oxide as a radioopacifier.
Interventions
To the best of our knowledge, no study has yet compared these three biomaterials in the treatment of permanent molars with incomplete root development.
To the best of our knowledge, no study has yet compared these three biomaterials in the treatment of permanent molars with incomplete root development.
To the best of our knowledge, no study has yet compared these three biomaterials in the treatment of permanent molars with incomplete root development.
Eligibility Criteria
You may qualify if:
- Healthy patients (according to ASA classification) with noncontributory medical history.
- Patients aged between 7 and 11 years of age, with at least one immature permanent molar with deep caries, needing full pulpotomy.
- Cooperative pediatric patients (Frankl's behavioral rating scale).
- Restorable immature permanent molar with deep caries: caries involving the pulpal roof or where complete caries removal would likely result in pulpal exposure.
- Physiological mobility.
- Vital pulp (detected by clinical signs/symptoms) presenting symptoms classically indicative of irreversible pulpitis according to AAE diagnostic criteria : positive but heightened response to cold sensibility testing, presence of spontaneous pain.
- No clinical signs of pulp necrosis; absence of a sinus tract or swelling.
- Patients who agree to return for periodic examination (follow-up).
- Patients who are willing to sign the consent form (written informed consent).
You may not qualify if:
- Medically compromised patients.
- Patients older than 11 years or younger than 7 years of age.
- Mature permanent molar.
- No signs and symptoms of irreversible pulpitis.
- No pulp exposure even after complete caries excavation.
- Clinical signs of pulp necrosis on the tooth to be treated, such as insufficient bleeding or no bleeding after pulp exposure.
- Uncontrollable pulp hemorrhage (more than 10 minutes of hemostasis).
- Teeth previously endodontically treated.
- Teeth with pathological root resorption.
- Impossibility to place a rubber dam.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universite Saint Joseph de Beyrouth
Beirut, Lebanon
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2025
First Posted
January 20, 2026
Study Start
October 1, 2025
Primary Completion (Estimated)
February 27, 2027
Study Completion (Estimated)
February 27, 2027
Last Updated
January 20, 2026
Record last verified: 2026-01